Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 3-(3-(4-(3-(glucopyranosyloxy)-5-isopropyl-1h-pyrazol-4-ylmethyl)-3-methylphenoxy)propylamino)-2,2-dimethylpropionamide
1. 666843-10-3
2. Mizagliflozin [inn]
3. Mizagliflozin [who-dd]
4. 1x96a704xv
5. Dsp-3235 Free Base
6. Kga-3235 Free Base
7. Mizagliflozin [inn:who-dd]
8. Unii-1x96a704xv
9. Gsk-1614235 Free Base
10. 3-((3-(4-((3-(beta-d-glucopyranosyloxy)-5-(propan-2-yl)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethylpropanamide
11. 3-((3-(4-((5-isopropyl-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethylpropanamide
12. Propanamide, 3-((3-(4-((3-(beta-d-glucopyranosyloxy)-5-(1-methylethyl)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethyl-
13. Schembl933325
14. Gtpl9547
15. Ex-a4127
16. S8939
17. Akos040742145
18. Hy-17638
19. Ms-30231
20. Cs-0016832
21. Gsk-1614235 Free Basedsp-3235 Free Base
22. Q27253060
23. 2,2-dimethyl-3-[3-[3-methyl-4-[[3-propan-2-yl-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2h-pyrazol-4-yl]methyl]phenoxy]propylamino]propanamide
24. 2,2-dimethyl-3-[3-[3-methyl-4-[[5-propan-2-yl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1h-pyrazol-4-yl]methyl]phenoxy]propylamino]propanamide
25. 3-((3-(4-((3-(.beta.-d-glucopyranosyloxy)-5-(propan-2-yl)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethylpropanamide
26. 3-(3-{4-[3-(beta-d-glucopyranosyloxy)-5-isopropyl-1h-pyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)-2,2-dimethylpropionamide
27. 3-[[3-[4-[[3-(beta-d-glucopyranosyloxy)-5-isopropyl-1h-pyrazole-4-yl]methyl]-3-methylphenoxy]propyl]amino]-2,2-dimethylpropanamide
28. Propanamide, 3-((3-(4-((3-(.beta.-d-glucopyranosyloxy)-5-(1-methylethyl)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethyl-
| Molecular Weight | 564.7 g/mol |
|---|---|
| Molecular Formula | C28H44N4O8 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 14 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 192 |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 789 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
17
PharmaCompass offers a list of Mizagliflozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mizagliflozin manufacturer or Mizagliflozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mizagliflozin manufacturer or Mizagliflozin supplier.
PharmaCompass also assists you with knowing the Mizagliflozin API Price utilized in the formulation of products. Mizagliflozin API Price is not always fixed or binding as the Mizagliflozin Price is obtained through a variety of data sources. The Mizagliflozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mizagliflozin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mizagliflozin, including repackagers and relabelers. The FDA regulates Mizagliflozin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mizagliflozin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mizagliflozin supplier is an individual or a company that provides Mizagliflozin active pharmaceutical ingredient (API) or Mizagliflozin finished formulations upon request. The Mizagliflozin suppliers may include Mizagliflozin API manufacturers, exporters, distributors and traders.
Mizagliflozin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mizagliflozin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mizagliflozin GMP manufacturer or Mizagliflozin GMP API supplier for your needs.
A Mizagliflozin CoA (Certificate of Analysis) is a formal document that attests to Mizagliflozin's compliance with Mizagliflozin specifications and serves as a tool for batch-level quality control.
Mizagliflozin CoA mostly includes findings from lab analyses of a specific batch. For each Mizagliflozin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mizagliflozin may be tested according to a variety of international standards, such as European Pharmacopoeia (Mizagliflozin EP), Mizagliflozin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mizagliflozin USP).
